ZA978450B - Medical treatment - Google Patents

Medical treatment

Info

Publication number
ZA978450B
ZA978450B ZA978450A ZA978450A ZA978450B ZA 978450 B ZA978450 B ZA 978450B ZA 978450 A ZA978450 A ZA 978450A ZA 978450 A ZA978450 A ZA 978450A ZA 978450 B ZA978450 B ZA 978450B
Authority
ZA
South Africa
Prior art keywords
medical treatment
medical
treatment
Prior art date
Application number
ZA978450A
Other languages
English (en)
Inventor
Clifford James Bailey
Robert Brian Jones
Helen Christine Jackson
Original Assignee
Knoll Aktiengesellscaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Knoll Aktiengesellscaft filed Critical Knoll Aktiengesellscaft
Publication of ZA978450B publication Critical patent/ZA978450B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Diabetes (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Electrotherapy Devices (AREA)
ZA978450A 1996-09-21 1997-09-19 Medical treatment ZA978450B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9619757.9A GB9619757D0 (en) 1996-09-21 1996-09-21 Chemical process

Publications (1)

Publication Number Publication Date
ZA978450B true ZA978450B (en) 1999-03-19

Family

ID=10800326

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA978450A ZA978450B (en) 1996-09-21 1997-09-19 Medical treatment

Country Status (26)

Country Link
US (3) US6174925B1 (no)
EP (1) EP0927028A1 (no)
JP (1) JP2001503737A (no)
KR (1) KR20000048501A (no)
CN (1) CN1237905A (no)
AU (1) AU724488B2 (no)
BG (1) BG64473B1 (no)
BR (1) BR9711517A (no)
CA (1) CA2266401C (no)
CZ (1) CZ93699A3 (no)
GB (1) GB9619757D0 (no)
HR (1) HRP970505A2 (no)
HU (1) HUP9904026A3 (no)
ID (1) ID18320A (no)
IL (1) IL128850A (no)
MY (1) MY116150A (no)
NO (1) NO991358L (no)
NZ (1) NZ334580A (no)
PL (1) PL332305A1 (no)
RU (1) RU2245709C2 (no)
SK (1) SK31999A3 (no)
TR (1) TR199900618T2 (no)
TW (1) TW580385B (no)
UA (1) UA64726C2 (no)
WO (1) WO1998011884A1 (no)
ZA (1) ZA978450B (no)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9619757D0 (en) * 1996-09-21 1996-11-06 Knoll Ag Chemical process
AR019727A1 (es) * 1998-06-30 2002-03-13 Takeda Chemical Industries Ltd Composicion farmaceutica
JP2000080047A (ja) * 1998-06-30 2000-03-21 Takeda Chem Ind Ltd 医 薬
US6339106B1 (en) 1999-08-11 2002-01-15 Sepracor, Inc. Methods and compositions for the treatment and prevention of sexual dysfunction
US6974838B2 (en) * 1998-08-24 2005-12-13 Sepracor Inc. Methods of treating or preventing pain using sibutramine metabolites
US6476078B2 (en) * 1999-08-11 2002-11-05 Sepracor, Inc. Methods of using sibutramine metabolites in combination with a phosphodiesterase inhibitor to treat sexual dysfunction
US6331571B1 (en) 1998-08-24 2001-12-18 Sepracor, Inc. Methods of treating and preventing attention deficit disorders
AR023700A1 (es) * 1998-11-12 2002-09-04 Smithkline Beecham Plc Un procedimiento para preparar una composicion farmaceutica que comprende un sensibilizador de insulina
US20040102486A1 (en) * 1998-11-12 2004-05-27 Smithkline Beecham Corporation Novel method of treatment
CN1230162C (zh) * 1998-11-12 2005-12-07 史密丝克莱恩比彻姆有限公司 改进释放胰岛素致敏剂和另一抗糖尿病药的药用组合物
US6323242B1 (en) 1998-12-02 2001-11-27 Peter Sterling Mueller Treatment of disorders secondary to organic impairments
US6696495B2 (en) 1998-12-02 2004-02-24 Snowden Pharmaceuticals, Llc Treatment of disorders secondary to organic impairments
US6552087B1 (en) 1999-03-19 2003-04-22 Abbott Gmbh & Co. Kg Therapeutic agent comprising (+)-sibutramine
US6680344B1 (en) 1999-06-01 2004-01-20 The University Of Texas Southwestern Medical Center Method of treating hair loss using diphenylmethane derivatives
EP1185232A1 (en) 1999-06-01 2002-03-13 University Of Texas Southwestern Medical Center Method of treating hair loss using sulfonyl thyromimetic compounds
US6723717B1 (en) 1999-06-01 2004-04-20 The University Of Texas Southwestern Medical Center Sulfur-containing thyroxane derivatives and their use as hair growth promotors
US6399826B1 (en) 1999-08-11 2002-06-04 Sepracor Inc. Salts of sibutramine metabolites, methods of making sibutramine metabolites and intermediates useful in the same, and methods of treating pain
WO2002083631A1 (en) * 2001-04-13 2002-10-24 Sepracor Inc. Methods of preparing didesmethylsibutramine and other sibutramine derivatives
PL376577A1 (pl) 2002-06-17 2006-01-09 Themis Laboratories Private Limited Wielowarstwowe tabletki zawierające tiazolidinedion i biguanidy oraz metody ich wytwarzania
CA2501321C (en) * 2002-10-05 2008-07-08 Hanmi Pharm. Co., Ltd. Pharmaceutical composition comprising crystalline sibutramine methanesulfonate hemihydrate
US20050131074A1 (en) * 2003-08-04 2005-06-16 Beckman Kristen M. Methods for treating metabolic syndrome
TW200517127A (en) * 2003-08-07 2005-06-01 Sb Pharmco Inc Novel composition
GB0318824D0 (en) * 2003-08-11 2003-09-10 Glaxo Group Ltd Novel composition
WO2005041962A1 (en) * 2003-10-31 2005-05-12 Takeda Pharmaceutical Company Limited Solid preparation comprising an insulin sensitizer, an insulin secretagogue and a polyoxyethylene sorbitan fatty acid ester
KR100627687B1 (ko) * 2005-04-20 2006-09-25 주식회사 씨티씨바이오 시부트라민 유리염기 함유 조성물 및 이의 제조방법
CN101394847B (zh) * 2006-01-06 2017-05-24 塞普拉柯公司 作为单胺重摄取抑制剂的环烷基胺类
AU2007296074B2 (en) 2006-09-15 2012-07-12 Reviva Pharmaceuticals, Inc. Synthesis, methods of using, and compositions of cycloalkylmethylamines
US8604244B2 (en) 2010-07-02 2013-12-10 Reviva Pharmaceuticals, Inc. Compositions, synthesis, and methods of using cycloalkylmethylamine derivatives
KR100812538B1 (ko) * 2006-10-23 2008-03-11 한올제약주식회사 약물 제어방출형 메트포르민-글리메피리드 복합제제
CN101528265A (zh) * 2006-11-22 2009-09-09 Sk化学株式会社 西布曲明和β-环糊精的包络物
CA2939778C (en) 2007-01-31 2019-01-29 Dana-Farber Cancer Institute, Inc. Stabilized p53 peptides and uses thereof
EP3159352B1 (en) 2007-03-28 2023-08-02 President and Fellows of Harvard College Stitched polypeptides
WO2012021876A2 (en) 2010-08-13 2012-02-16 Aileron Therapeutics, Inc. Peptidomimetic macrocycles
WO2013059525A1 (en) 2011-10-18 2013-04-25 Aileron Therapeutics, Inc. Peptidomimetic macrocyles
SG11201403165SA (en) 2011-12-30 2014-08-28 Reviva Pharmaceuticals Inc Compositions, synthesis, and methods of using phenylcycloalkylmethylamine derivatives
CN104144695A (zh) 2012-02-15 2014-11-12 爱勒让治疗公司 三唑交联的和硫醚交联的拟肽大环化合物
CA2862038C (en) 2012-02-15 2021-05-25 Aileron Therapeutics, Inc. Peptidomimetic macrocycles
SG11201503052RA (en) 2012-11-01 2015-05-28 Aileron Therapeutics Inc Disubstituted amino acids and methods of preparation and use thereof
CA2961258A1 (en) 2014-09-24 2016-03-31 Aileron Therapeutics, Inc. Peptidomimetic macrocycles and uses thereof
CA2979847A1 (en) 2015-03-20 2016-09-29 Aileron Therapeutics, Inc. Peptidomimetic macrocycles and uses thereof

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE52768B1 (en) * 1981-04-06 1988-02-17 Boots Co Ltd 1-arylcyclobutylalkylamine compounds useful as therapeutic agents
GB8531071D0 (en) * 1985-12-17 1986-01-29 Boots Co Plc Therapeutic compound
GB8704777D0 (en) * 1987-02-28 1987-04-01 Boots Co Plc Medical treatment
JP2675573B2 (ja) * 1988-03-31 1997-11-12 科研製薬株式会社 脳機能改善剤
IE61928B1 (en) * 1988-11-29 1994-11-30 Boots Co Plc Treatment of obesity
WO1995010292A1 (en) 1993-10-14 1995-04-20 Biomedica California, Inc. Diabetes treatment and prophylaxis
US5459164A (en) * 1994-02-03 1995-10-17 Boots Pharmaceuticals, Inc. Medical treatment
GB9619757D0 (en) * 1996-09-21 1996-11-06 Knoll Ag Chemical process

Also Published As

Publication number Publication date
GB9619757D0 (en) 1996-11-06
TR199900618T2 (xx) 1999-06-21
MY116150A (en) 2003-11-28
PL332305A1 (en) 1999-08-30
NO991358D0 (no) 1999-03-19
BG103277A (en) 2000-01-31
HUP9904026A3 (en) 2000-07-28
SK31999A3 (en) 1999-12-10
US6617360B1 (en) 2003-09-09
ID18320A (id) 1998-03-26
CA2266401C (en) 2007-01-30
CA2266401A1 (en) 1998-03-26
NZ334580A (en) 2000-09-29
RU2245709C2 (ru) 2005-02-10
KR20000048501A (ko) 2000-07-25
IL128850A0 (en) 2000-01-31
CZ93699A3 (cs) 1999-08-11
HUP9904026A2 (hu) 2000-05-28
US20040077730A1 (en) 2004-04-22
IL128850A (en) 2003-07-31
US6174925B1 (en) 2001-01-16
TW580385B (en) 2004-03-21
NO991358L (no) 1999-03-19
JP2001503737A (ja) 2001-03-21
WO1998011884A1 (en) 1998-03-26
AU4774097A (en) 1998-04-14
HRP970505A2 (en) 1998-08-31
EP0927028A1 (en) 1999-07-07
BR9711517A (pt) 1999-08-24
CN1237905A (zh) 1999-12-08
BG64473B1 (bg) 2005-04-30
AU724488B2 (en) 2000-09-21
UA64726C2 (uk) 2004-03-15

Similar Documents

Publication Publication Date Title
IL128850A0 (en) Medical treatment
GB9411080D0 (en) Treatment
GB9617502D0 (en) Medical devices
GB9610682D0 (en) Medical devices
GB2303303B (en) Medical treatment
GB9521725D0 (en) Medical treatment
GB9408084D0 (en) Medical treatment
GB9608657D0 (en) Novel treatment
GB9526264D0 (en) Medical treatment
GB9617550D0 (en) Medical ice-pack
GB9602728D0 (en) Medical treatment
GB9626265D0 (en) Medical treatment
GB9618375D0 (en) Medical treatment
GB9612330D0 (en) Medical treatment
GB9621327D0 (en) Medical treatment
GB9626859D0 (en) Medical treatment
GB9601042D0 (en) Medical use
GB9710544D0 (en) Medical treatment
GB9425773D0 (en) Medical treatment
GB9403306D0 (en) Medical treatment
GB9425164D0 (en) Medical treatment
GB9421398D0 (en) Medical treatment
GB9424728D0 (en) Medical treatment
GB2307858B (en) Medical treatment
GB9612752D0 (en) Novel treatment